1. Five‐year follow‐up observation of interventional therapy for lower extremity vascular disease in type 2 diabetes and analysis of risk factors for restenosis
- Author
-
Lin Hou, Hong-Fang Ma, Na Xing, Chaoxi Zhou, Haixia Ding, Yaping Du, and Fujun Wang
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,030209 endocrinology & metabolism ,Type 2 diabetes ,030204 cardiovascular system & hematology ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Restenosis ,Recurrence ,Risk Factors ,Diabetes mellitus ,Internal medicine ,medicine ,Humans ,Vascular Patency ,Aged ,Retrospective Studies ,Glycated Hemoglobin ,Vascular disease ,business.industry ,Retrospective cohort study ,Cholesterol, LDL ,Middle Aged ,medicine.disease ,Blood pressure ,Diabetes Mellitus, Type 2 ,chemistry ,Cardiology ,Female ,Glycated hemoglobin ,business ,Vascular Surgical Procedures ,Diabetic Angiopathies ,Follow-Up Studies - Abstract
The high incidence of type 2 diabetes, the low rate of compliance, and the complex mechanism of vascular disease caused by diabetes make its complications increase year by year. Our study aimed to investigate the clinical characteristics of lower extremity vascular diseases in type 2 diabetes and evaluate the long-term efficacy of vascular intervention for these diseases.From 2007 to 2014, 362 patients who underwent vascular intervention in our hospital due to lower extremity vascular diseases in type 2 diabetes were followed up for 5 years and their clinical characteristics were analyzed in this retrospective study.Compared with those before treatment, the values of blood pressure, fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol (TC), triglyceride Ester (TG), and low density lipoprotein-cholesterol (LDL-C) of patients were significantly lower 5 years after intervention (P 0.01). We found that the levels of fibrinogen, blood glucose, HbA1c, TC, TG, LDL-C, and small dense low-density lipoprotein (sdLDL) in the vascular restenosis group were significantly higher than those in the vascular patency group (P 0.001), whereas the level of HDL-C in the vascular restenosis group was significantly lower compared with the vascular patency group.Vascular intervention can significantly improve a series of biochemical indicators in patients with lower extremity vascular diseases caused by type 2 diabetes. Postoperative restenosis may be related to hypertension, duration of diabetes, rate of inferior knee disease, fibrinogen, and sdLDL. Good survival and limb salvage were achieved in the patients in this series with interventions and medical treatment provided by endocrinologists.背景: 2型糖尿病的高发病率、低依从性以及由糖尿病引起的血管疾病的复杂机制使其并发症逐年增加。本研究旨在探讨2型糖尿病合并下肢血管病变临床特点及下肢血管介入治疗的远期疗效和临床意义。 方法: 对2007-2014年间因糖尿病下肢血管病变于我院行下肢血管病变介入治疗的362例患者进行5年疗效随访, 并对其临床特点进行分析。 结果: 与治疗前相比,患者的血压、空腹血糖、糖化血红蛋白(HbA1c)、总胆固醇(TC)、三酰甘油(TG)和低密度脂蛋白胆固醇(LDL-C)在干预5年后明显降低(P0.01)。与血管通畅组相比,血管再狭窄组患者的纤维蛋白原、血糖、HbA1c、TC、TG、LDL-C和小而密低密度脂蛋白(sdLDL)水平较高,而HDL-C水平较低。 结论: 血管介入治疗可以显着改善由2型糖尿病引起的下肢血管疾病患者的一系列生化指标。术后再狭窄可能与高血压、糖尿病持续时间、膝下疾病发生率、纤维蛋白原和sdLDL有关。通过内分泌科医师治疗和干预下,该系列患者获得了良好的生存和肢体挽救。.
- Published
- 2020
- Full Text
- View/download PDF